Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy?
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse......(read more)
Posts Tagged ‘NASDAQ:FOLD’
Amicus Therapeutics, Inc. (FOLD) Hedge Funds Are Snapping Up
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or......(read more)
Hedge Fund and Insider Trading News: Warren Buffett, Elliott Management, Mcdonald’s Corp (MCD), GTT Communications Inc (GTT), Butler National Co. (BUKS), and More
Warren Buffett’s Firm Invests Millions in Fintech (The Wall Street Journal) Warren Buffett’s Berkshire Hathaway Inc. is hopping on the fintech bandwagon......(read more)
Hedge Fund and Insider Trading News: Ken Griffin, Carl Icahn, Howard Hughes Corp (HHC), Amicus Therapeutics, Inc. (FOLD), Falcon Minerals Corp (FLMN), and More
Ken Griffin Hires Two Moore Capital Veterans for Macro Expansion (Bloomberg) Billionaire Ken Griffin hired two veteran money managers from Louis Bacon......(read more)
Hedge Fund and Insider Trading News: Bill Miller, John Paulson, Warren Buffett, Amicus Therapeutics, Inc. (FOLD), Workday Inc (WDAY), and More
Famed Value Investor Bill Miller Says Facebook Stock has Gotten Too Cheap: ‘This Too will Pass’ (CNBC) Famed investor Bill Miller is still......(read more)
Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration......(read more)
Amicus Therapeutics, Inc. (FOLD) Announces The Closure Of Its Senior Convertible Notes
Amicus Therapeutics, Inc. (NASDAQ:FOLD) says that it will be closing its previously announced private offering of $250 million aggregate principal amount......(read more)
Amicus Therapeutics, Inc. (FOLD): Breaking Down The Raise
Amicus Therapeutics, Inc. (NASDAQ:FOLD) just announced a convertible senior notes offering, and the company is trending down on he back of the news. Here......(read more)
Is Amicus Therapeutics, Inc. (FOLD) A Good Stock To Buy?
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors......(read more)
Biotech Movers And Shakers: Nivalis Therapeutics Inc (NVLS) And Amicus Therapeutics, Inc. (FOLD)
It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at. It’s been......(read more)
Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven......(read more)
Biotech Gainers On Tuesday: Amicus Therapeutics, Inc. (FOLD) And Ionis Pharmaceuticals Inc (IONS)
While wider markets turn there focus to the US elections, the biotech space is alive and well, and after a tough end to last week, a number of companies......(read more)
Big Bet on Sarepta Therapeutics Inc (SRPT) Lifts Perceptive Advisors’ Q3 Returns; See How Other Investments Performed
Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......(read more)
Five Cheap Healthcare Stocks Poised to Explode
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk......(read more)
Redmile Group Sticking With Healthcare Picks After Rough Q1
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......(read more)
Amicus Therapeutics, Inc. (FOLD): Small-Cap Biotech with Large Hedge Fund Ownership
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s lead drug candidate is migalastat, which targets Fabry disease. An estimated 1 in 40,000 to 60,000 males......(read more)
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’......(read more)
Why Valeant, Micron, and Three Other Stocks Are in Green Territory on Friday?
Oil went back to tumbling on Friday, with crude oil losing more than 3.5%. On the other hand, markets returned to positive territory, with major U.S.......(read more)
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top......(read more)
Redmile Group’s Top Q4 Moves as Its Long Positions Show Gains of 20% in 2015
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector. Redmile has an equity......(read more)
Five Cheap Healthcare Stocks Poised to Explode
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary......(read more)
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since......(read more)
Are Hedge Funds Dumping Amicus Therapeutics, Inc. (FOLD)?
The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997. The two relatively......(read more)
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore......(read more)
Are The Gains In These Hot Monday Stocks Sustainable?
It’s a good Monday for investors of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), Amicus Therapeutics, Inc. (NASDAQ:FOLD), and Oasis Petroleum Inc. (......(read more)
Something that Might Change Your Mind About Two of These Three Falling Stocks
Three stocks trending significantly low today before afternoon were Amicus Therapeutics, Inc. (NASDAQ:FOLD), which cratered by more than 40%, Teladoc......(read more)
Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman’s Top Healthcare Picks
Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded......(read more)
Tuesday Morning Corporation (TUES), Swift Transportation Co (SWFT), Amicus Therapeutics, Inc. (FOLD): Citadel’s Latest Moves
Ken Griffin‘s Citadel Investment Group has increased its stakes in Tuesday Morning Corporation (NASDAQ:TUES), Swift Transportation Co (NYSE:SWFT......(read more)
Amicus Therapeutics, Inc. (FOLD): Redmile Group Trims Position and Books Some Profits from Long-Term Investment
Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’......(read more)
Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to......(read more)
Perceptive Advisors Buys 4.0 Million Shares Of Amicus Therapeutics Inc. (FOLD)
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange......(read more)
Jeremy Green, Redmile Group Boost Position in Amicus Therapeutics, Inc. (FOLD)
Jeremy Green‘s Redmile Group has significantly surged its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD), a new filing with the SEC revealed......(read more)
Hedge Funds Are Selling BioDelivery Sciences International, Inc. (BDSI)
Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to......(read more)
This Metric Says You Are Smart to Buy Amicus Therapeutics, Inc. (FOLD)
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment......(read more)
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,......(read more)
Hedge Funds Are Buying ZIOPHARM Oncology Inc. (ZIOP)
Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a buy, sell, or hold? The best stock pickers are taking a bullish view. The number of bullish hedge fund bets......(read more)
Hedge Funds Are Buying Amicus Therapeutics, Inc. (FOLD)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm......(read more)
Is BioDelivery Sciences International, Inc. (BDSI) Going to Burn These Hedge Funds?
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a......(read more)
Pain Therapeutics, Inc. (PTIE): Are Hedge Funds Right About This Stock?
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed......(read more)
Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund......(read more)
Are These 3 Stocks Down for the Count?: Ruckus Wireless Inc (RKUS) and More
Horse meat and Wal-Mart Stores, Inc. (NYSE:WMT) jockeyed for position in sending the Dow Jones Industrial Average lower on Friday, but the index fought......(read more)
This Week in Biotech: AbbVie Inc (ABBV) and More
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
3 Horrendous Health-Care Stocks This Week: Amicus Therapeutics, Inc. (FOLD) and More
The Ides of March meant bad news for Julius Caesar. Similarly, the week surrounding the Ides of February haven’t turned out so well for several......(read more)
Issuing More Shares: Good or Bad? – Buckeye Partners, L.P. (BPL), Citigroup Inc. (C) and More
Buckeye Partners, L.P. (NYSE:BPL) recently announced plans to issue additional limited partnership units. Citigroup Inc. (NYSE:C) issued preferred shares......(read more)
